Russell Investments Group, Ltd. Corcept Therapeutics Inc Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 181,223 shares of CORT stock, worth $9.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
181,223
Previous 89,330 102.87%
Holding current value
$9.27 Million
Previous $2.9 Million 188.87%
% of portfolio
0.01%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$29.51 - $46.26 $2.71 Million - $4.25 Million
91,893 Added 102.87%
181,223 $8.38 Million
Q2 2024

Aug 08, 2024
SELL
$22.21 - $34.48 $436,359 - $677,428
-19,647 Reduced 18.03%
89,330 $2.9 Million
Q1 2024

May 08, 2024
BUY
$21.1 - $27.46 $1.89 Million - $2.46 Million
89,655 Added 464.0%
108,977 $2.75 Million
Q4 2023

Feb 05, 2024
SELL
$24.82 - $32.88 $55,472 - $73,486
-2,235 Reduced 10.37%
19,322 $627,000
Q3 2023

Nov 13, 2023
BUY
$21.97 - $33.8 $470,267 - $723,488
21,405 Added 14082.24%
21,557 $587,000
Q2 2023

Aug 10, 2023
BUY
$21.44 - $25.15 $3,258 - $3,822
152 New
152 $3,000
Q3 2022

Nov 04, 2022
SELL
$24.7 - $29.12 $268,242 - $316,243
-10,860 Reduced 26.06%
30,813 $786,000
Q2 2022

Jul 29, 2022
BUY
$17.33 - $25.3 $45,803 - $66,867
2,643 Added 6.77%
41,673 $1.02 Million
Q1 2022

May 05, 2022
BUY
$16.53 - $25.21 $135,827 - $207,150
8,217 Added 26.67%
39,030 $930,000
Q4 2021

Jan 21, 2022
SELL
$17.1 - $23.34 $872 - $1,190
-51 Reduced 0.17%
30,813 $600,000
Q3 2021

Nov 08, 2021
SELL
$19.68 - $22.53 $43,551 - $49,858
-2,213 Reduced 6.69%
30,864 $613,000
Q2 2021

Aug 04, 2021
BUY
$19.97 - $24.43 $104,503 - $127,842
5,233 Added 18.79%
33,077 $733,000
Q1 2021

May 10, 2021
SELL
$23.49 - $30.56 $82,027 - $106,715
-3,492 Reduced 11.14%
27,844 $655,000
Q4 2020

Feb 08, 2021
SELL
$16.78 - $27.3 $2.28 Million - $3.72 Million
-136,091 Reduced 81.28%
31,336 $820,000
Q3 2020

Nov 09, 2020
SELL
$12.46 - $19.98 $2.76 Million - $4.43 Million
-221,908 Reduced 57.0%
167,427 $2.91 Million
Q2 2020

Aug 05, 2020
BUY
$11.0 - $18.26 $2.6 Million - $4.32 Million
236,757 Added 155.17%
389,335 $6.54 Million
Q1 2020

May 06, 2020
BUY
$10.11 - $14.04 $1.54 Million - $2.14 Million
152,578 New
152,578 $1.81 Million
Q4 2019

Jan 29, 2020
SELL
$12.06 - $16.96 $82,888 - $116,566
-6,873 Closed
0 $0
Q3 2019

Nov 01, 2019
SELL
$10.41 - $14.66 $970,638 - $1.37 Million
-93,241 Reduced 93.13%
6,873 $100,000
Q2 2019

Aug 09, 2019
SELL
$9.78 - $12.76 $207,032 - $270,116
-21,169 Reduced 17.45%
100,114 $1.12 Million
Q1 2019

May 13, 2019
BUY
$10.03 - $15.71 $261,913 - $410,235
26,113 Added 27.44%
121,283 $1.42 Million
Q4 2018

Feb 11, 2019
SELL
$11.29 - $17.19 $37,731 - $57,448
-3,342 Reduced 3.39%
95,170 $1.27 Million
Q3 2018

Oct 26, 2018
SELL
$12.27 - $15.65 $3.35 Million - $4.27 Million
-272,971 Reduced 73.48%
98,512 $1.38 Million
Q2 2018

Aug 08, 2018
SELL
$15.3 - $19.69 $6.29 Million - $8.1 Million
-411,331 Reduced 52.55%
371,483 $5.85 Million
Q1 2018

May 11, 2018
SELL
$14.59 - $25.5 $874,437 - $1.53 Million
-59,934 Reduced 7.11%
782,814 $12.9 Million
Q4 2017

Feb 06, 2018
SELL
$15.77 - $20.72 $303,730 - $399,067
-19,260 Reduced 2.23%
842,748 $15.3 Million
Q3 2017

Nov 07, 2017
BUY
$12.3 - $19.3 $10.6 Million - $16.6 Million
862,008
862,008 $16.6 Million

Others Institutions Holding CORT

# of Institutions
346
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.48B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email